Back to Journals » Cancer Management and Research » Volume 5

Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
9,799 Dovepress* 8,806+ 1,715 10,521
PubMed Central* 993 252 1,245
Totals 9,799 1,967 11,766
*Since 17 January 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar